Results 111 to 120 of about 29,949 (204)

In vitro stability of enoxaparin solutions (20 mg/mL) diluted in 4% glucose

, 2008
Background: Enoxaparin is an antithrombotic used for the prophylaxis of pediatric patients. Treatment can extend over weeks or months but there is no commercial pediatric dosage form of enoxaparin available.
Glenn Jacobson (14740078), Rahul Patel (14746363), Christian Narkowicz (14745160)   +2 more
core  

Enoxaparin [PDF]

, 2020
openaire   +1 more source

A Case of an Allergic Contact Dermatitis Following the Administration of Enoxaparin: A Case Report and Review of the Literature

Clinical Medicine Insights: Case Reports
Introduction: Allergic contact dermatitis (ACD) is a rare but clinically significant hypersensitivity reaction to certain medications, including enoxaparin, a commonly used low-molecular-weight heparin (LMWH) for venous thromboembolism (VTE) prophylaxis.
Hend M. Alotaibi, Alhanoof Alajlan, Abdulrahman Alluhaybi, Ahmed A. Alhumidi   +3 more
doaj   +1 more source

Clinical outcomes following a hospital-wide transition from enoxaparin to tinzaparin for venous thromboembolism prophylaxis in neurosurgical patients. [PDF]

Acta Neurochir (Wien)
Ritter L, Liebert A, Weigel J, Schebesch KM, Eibl T.   +4 more
europepmc   +1 more source

Evaluation of Enoxaparin Dosing in Infants Greater Than 2 to 6 Months of Age, a Pre and Post Quasi Experiment. [PDF]

J Pediatr Pharmacol Ther
Djordjevich CJ, Cloyd C, Wysocki E, Yildiz VO, Rodriguez V.   +4 more
europepmc   +1 more source

Aspirin-Based Thromboprophylaxis Versus Anticoagulant Regimens After Total Hip or Knee Arthroplasty: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Medicina (Kaunas)
Al Chalabi H, Amro O, Gordon A, Al-Abbasi G.   +3 more
europepmc   +1 more source

The impact of enoxaparin on ovarian torsion-detorsion damage in rats. [PDF]

Acta Cir Bras
Altun E, Lafci D, Usta CS, Yaranoglu MH, Guler EM.   +4 more
europepmc   +1 more source

Anticoagulation Monitoring in Recurrent Venous Thromboembolism Associated With Antiphospholipid Antibodies and Subsequent Heparin-Induced Thrombocytopenia. [PDF]

Cureus
Bechir G.
europepmc   +1 more source

Intermediate-Dose Tinzaparin Versus Low-Dose Enoxaparin as Thromboprophylaxis in Hospitalized Internal Medicine Patients. [PDF]

Med Sci (Basel)
Kaklamanos A, Serepisios V, Chelioti S, Zervakou K, Christodoulou G, Pouliakis A, Mikelopoulou K, Germanou D, Tsinokou I, Papadakis DD, Tsironis C, Androutsakos T.   +11 more
europepmc   +1 more source

Perspectives: what we are learning from factor XI/factor XIa inhibitor trials. [PDF]

Res Pract Thromb Haemost
Glasner MF, Weitz JI, Al-Lamee R, Bahit MC, Coutinho JM, Johnston SC, Gailani D, Lam CSP, Wang TF, Winkelmayer WC.   +9 more
europepmc   +1 more source